Title:
A combined therapy accompanied by the antibody to Claudin 18.2 for dealing with cancer
Document Type and Number:
Japanese Patent JP6203830
Kind Code:
B2
Abstract:
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
More Like This:
Inventors:
Ughur Shahin
Utzlem Thulec
Rita Mitt Nacht-Klaus
Stephan Dennis Jacobs
Magdalena Yadwiga Ush
Cornelia Adriana Maria Heinz
Christiane Regina Stadler
Utzlem Thulec
Rita Mitt Nacht-Klaus
Stephan Dennis Jacobs
Magdalena Yadwiga Ush
Cornelia Adriana Maria Heinz
Christiane Regina Stadler
Application Number:
JP2015513043A
Publication Date:
September 27, 2017
Filing Date:
May 21, 2013
Export Citation:
Assignee:
Ganymed Pharmaceuticals AG
TRON-Translationare on Corogee an der Universitate Smedizin der Johannes Gutenberg-Universitate Mainz Gemainn Nutsige Geembehr
TRON-Translationare on Corogee an der Universitate Smedizin der Johannes Gutenberg-Universitate Mainz Gemainn Nutsige Geembehr
International Classes:
A61K39/395; A61K31/282; A61K31/337; A61K31/4745; A61K31/513; A61K31/519; A61K31/663; A61K31/704; A61K33/243; A61K38/20; A61P35/00
Domestic Patent References:
JP2010528075A | ||||
JP2009517354A | ||||
JP2011510632A | ||||
JP2011529172A |
Foreign References:
WO2008152822A1 | ||||
WO2010141093A1 | ||||
WO2011090005A1 |
Other References:
ANTICANCER RESEARCH, 2011, Vol. 31, p. 3691-3696
Breast Cancer Research, 2002, Vol.4, No.1, p.30-34
Breast Cancer Research, 2002, Vol.4, No.1, p.30-34
Attorney, Agent or Firm:
Yasuhiko Murayama
Masatake Shiga
Takashi Watanabe
Shinya Mitsuhiro
Masatake Shiga
Takashi Watanabe
Shinya Mitsuhiro